As of 2025-07-18, the Relative Valuation of Allovir Inc (ALVR) is (414.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.81 USD, the upside of Allovir Inc based on Relative Valuation is -4322.7%.
The range of the Relative Valuation is (261.53) - (515.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 27.0x | 20.2x |
| Forward P/E multiples | 13.7x - 32.7x | 23.2x |
| Fair Price | (261.53) - (515.42) | (414.24) |
| Upside | -2765.9% - -5354.0% | -4322.7% |
| Date | P/E |
| 2025-05-09 | -0.18 |
| 2025-05-08 | -0.20 |
| 2025-05-07 | -0.23 |
| 2025-05-06 | -0.25 |
| 2025-05-05 | -0.28 |
| 2025-05-02 | -0.31 |
| 2025-05-01 | -0.31 |
| 2025-04-30 | -0.33 |
| 2025-04-29 | -0.36 |
| 2025-04-28 | -0.35 |
| 2025-04-25 | -0.35 |
| 2025-04-24 | -0.34 |
| 2025-04-23 | -0.37 |
| 2025-04-22 | -0.35 |
| 2025-04-21 | -0.35 |